Integral Ad Science (NASDAQ:IAS) Hits New 12-Month Low After Analyst Downgrade

Shares of Integral Ad Science Holding Corp. (NASDAQ:IASGet Free Report) hit a new 52-week low on Monday after Barclays lowered their price target on the stock from $14.00 to $7.00. Barclays currently has an equal weight rating on the stock. Integral Ad Science traded as low as $6.26 and last traded at $6.29, with a volume of 46370 shares trading hands. The stock had previously closed at $6.52.

Other research analysts also recently issued research reports about the stock. Baird R W downgraded shares of Integral Ad Science from a “strong-buy” rating to a “hold” rating in a research report on Friday, March 28th. Morgan Stanley reduced their price target on Integral Ad Science from $13.50 to $12.50 and set an “equal weight” rating on the stock in a research report on Thursday, April 17th. Robert W. Baird reiterated a “neutral” rating and set a $9.00 price objective (down previously from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Truist Financial boosted their target price on Integral Ad Science from $16.00 to $17.00 and gave the stock a “buy” rating in a research note on Monday, March 3rd. Finally, Scotiabank assumed coverage on Integral Ad Science in a report on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price target for the company. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $13.75.

Read Our Latest Report on Integral Ad Science

Insider Activity

In other Integral Ad Science news, CEO Lisa Utzschneider sold 68,671 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $7.44, for a total value of $510,912.24. Following the sale, the chief executive officer now owns 334,051 shares in the company, valued at approximately $2,485,339.44. This represents a 17.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders have sold 90,303 shares of company stock valued at $706,660 in the last ninety days. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Integral Ad Science by 4.6% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company’s stock valued at $433,000 after purchasing an additional 1,832 shares in the last quarter. Jennison Associates LLC increased its stake in Integral Ad Science by 3.3% during the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company’s stock worth $663,000 after buying an additional 2,046 shares in the last quarter. Oppenheimer & Co. Inc. raised its holdings in shares of Integral Ad Science by 8.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company’s stock valued at $293,000 after acquiring an additional 2,069 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Integral Ad Science by 7.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company’s stock worth $332,000 after acquiring an additional 2,188 shares during the last quarter. Finally, Arizona State Retirement System increased its position in shares of Integral Ad Science by 12.5% during the fourth quarter. Arizona State Retirement System now owns 23,404 shares of the company’s stock worth $244,000 after purchasing an additional 2,601 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Stock Down 2.1 %

The company has a market cap of $1.05 billion, a PE ratio of 31.90, a price-to-earnings-growth ratio of 1.06 and a beta of 1.53. The business has a fifty day simple moving average of $8.76 and a two-hundred day simple moving average of $10.07. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IASGet Free Report) last released its quarterly earnings data on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). The business had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.06 EPS. As a group, equities research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Further Reading

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.